European Commission Approves Abecma, or idecabtagene vicleucel, for Earlier Lines of Therapy for Triple-Class Exposed Relapsed and Refractory Multiple Myeloma Read more about European Commission Approves Abecma, or idecabtagene vicleucel, for Earlier Lines of Therapy for Triple-Class Exposed Relapsed and Refractory Multiple Myeloma Add new comment
Myeloma Survivor, Advocate, and… Disruptor! Read more about Myeloma Survivor, Advocate, and… Disruptor!Add new comment
FDA ODAC Votes in Favor of Abecma, or idecabtagene vicleucel, in Earlier Lines of Therapy for Triple-Class Exposed Multiple Myeloma Read more about FDA ODAC Votes in Favor of Abecma, or idecabtagene vicleucel, in Earlier Lines of Therapy for Triple-Class Exposed Multiple Myeloma Add new comment
FDA ODAC Recommends CARVYKTI (ciltacabtagene autoleucel) for Earlier Treatment of Patients with Relapsed or Refractory Multiple Myeloma Read more about FDA ODAC Recommends CARVYKTI (ciltacabtagene autoleucel) for Earlier Treatment of Patients with Relapsed or Refractory Multiple MyelomaAdd new comment
Lifelong Philanthropist and 17-year Myeloma Survivor John O’Dwyer Elected to the International Myeloma Foundation’s Board of Directors Read more about Lifelong Philanthropist and 17-year Myeloma Survivor John O’Dwyer Elected to the International Myeloma Foundation’s Board of Directors Add new comment
Myeloma Support Group Leader Voices at ASH Read more about Myeloma Support Group Leader Voices at ASHAdd new comment
DREAMM-8 Phase III Trial for Blenrep Demonstrates Positive Results Read more about DREAMM-8 Phase III Trial for Blenrep Demonstrates Positive ResultsAdd new comment
Uniting Voices, Connecting Lives: Empowering Myeloma Communities Together Read more about Uniting Voices, Connecting Lives: Empowering Myeloma Communities Together Add new comment
February 2024 – Myeloma News from the Journals Read more about February 2024 – Myeloma News from the JournalsAdd new comment
International Myeloma Foundation (IMF) Launches #MyelomaActionMonth for 2024 March Myeloma Action Month Read more about International Myeloma Foundation (IMF) Launches #MyelomaActionMonth for 2024 March Myeloma Action Month Add new comment
